Phase I/II clinical trial of temsirolimus and lenalidomide in patients with relapsed and refractory lymphomas
Major, Ajay, Kline, Justin, Karrison, Theodore G., Fishkin, Paul A. S., Kimball, Amy S., Petrich, Adam M., Nattam, Sreenivasa, Rao, Krishna, Sleckman, Bethany G., Cohen, Kenneth, Besien, Koen van, Rapoport, Aaron P., Smith, Sonali M.
Published in Haematologica (Roma) (01.07.2022)
Published in Haematologica (Roma) (01.07.2022)
Get full text
Journal Article
Pulmonary Sarcomatoid Carcinomas Commonly Harbor Either Potentially Targetable Genomic Alterations or High Tumor Mutational Burden as Observed by Comprehensive Genomic Profiling
Schrock, Alexa B., Li, Shuyu D., Frampton, Garrett M., Suh, James, Braun, Eduardo, Mehra, Ranee, Buck, Steven C., Bufill, Jose A., Peled, Nir, Karim, Nagla Abdel, Hsieh, K. Cynthia, Doria, Manuel, Knost, James, Chen, Rong, Ou, Sai-Hong Ignatius, Ross, Jeffrey S., Stephens, Philip J., Fishkin, Paul, Miller, Vincent A., Ali, Siraj M., Halmos, Balazs, Liu, Jane J.
Published in Journal of thoracic oncology (01.06.2017)
Published in Journal of thoracic oncology (01.06.2017)
Get full text
Journal Article
Long-Term Follow-Up of the RESORT Study (E4402): A Randomized Phase III Comparison of Two Different Rituximab Dosing Strategies for Low-Tumor Burden Follicular Lymphoma
Kahl, Brad S, Jegede, Opeyemi A, Peterson, Christopher, Swinnen, Lode J, Habermann, Thomas M, Schuster, Stephen J, Weiss, Matthias, Fishkin, Paul A, Fenske, Timothy S, Williams, Michael E
Published in Journal of clinical oncology (01.03.2024)
Published in Journal of clinical oncology (01.03.2024)
Get full text
Journal Article
Long‐term results of the treatment of patients with mantle cell lymphoma with cladribine (2‐CDA) alone (95‐80‐53) or 2‐CDA and rituximab (N0189) in the North Central Cancer Treatment Group
Inwards, David J., Fishkin, Paul A. S., Hillman, David W., Brown, David W., Ansell, Stephen M., Kurtin, Paul J., Fonseca, Rafael, Morton, Roscoe F., Veeder, Michael H., Witzig, Thomas E.
Published in Cancer (01.07.2008)
Published in Cancer (01.07.2008)
Get full text
Journal Article
Tetracycline to Prevent Epidermal Growth Factor Receptor Inhibitor-induced Skin Rashes : Results of a Placebo-controlled Trial From the North Central Cancer Treatment Group (N03CB)
JATOI, Aminah, ROWLAND, Kendrith, LOPRINZI, Charles L, SLOAN, Jeff A, GROSS, Howard M, FISHKIN, Paul A, KAHANIC, Stephen P, NOVOTNY, Paul J, SCHAEFER, Paul L, JOHNSON, David B, TSCHETTER, Loren K
Published in Cancer (15.08.2008)
Published in Cancer (15.08.2008)
Get full text
Journal Article
Fulvestrant in Women With Advanced Breast Cancer After Progression on Prior Aromatase Inhibitor Therapy: North Central Cancer Treatment Group Trial N0032
INGLE, James N, SUMAN, Vera J, ROWLAND, Kendrith M, MIRCHANDANI, Deepu, BERNATH, Albert M, CAMORIANO, John K, FISLIKIN, Paul A. S, NIKCEVICH, Daniel A, PEREZ, Edith A
Published in Journal of clinical oncology (01.03.2006)
Published in Journal of clinical oncology (01.03.2006)
Get full text
Journal Article
Phase II Interventional Study (N0337) of Capecitabine in Combination With Vinorelbine and Trastuzumab for First- or Second-Line Treatment of HER2-Positive Metastatic Breast Cancer: A North Central Cancer Treatment Group Trial
Tan, Winston W, Allred, Jacob B, Salim, Muhammad, Flynn, Patrick, Fishkin, Paul A.S, Stella, Philip J, Wiesenfeld, Martin, Bernath, Albert M, Fitch, Tom R, Perez, Edith A
Published in Clinical breast cancer (01.04.2012)
Published in Clinical breast cancer (01.04.2012)
Get full text
Journal Article
Long-term outcome of a phase II study of docetaxel-based multimodality chemoradiotherapy for locally advanced carcinoma of the esophagus or gastroesophageal junction
Choong, Nicholas W., Mauer, Ann M., Haraf, Daniel C., Ferguson, Mark K., Sandler, Alan B., Kesler, Kenneth A., Fishkin, Paul A. S., Ansari, Rafat H., Wade, James, Krauss, Stuart A., Sciortino, David F., Posner, Mitchell C., Kocherginsky, Masha, Hoffman, Philip C., Szeto, Livia, Vokes, Everett E.
Published in Medical oncology (Northwood, London, England) (01.12.2011)
Published in Medical oncology (Northwood, London, England) (01.12.2011)
Get full text
Journal Article
Phase II trial of dolastatin-10 in patients with advanced breast cancer
Perez, Edith A, Hillman, David W, Fishkin, Paul A, Krook, James E, Tan, Winston W, Kuriakose, Phillip A, Alberts, Steven R, Dakhil, Shaker R
Published in Investigational new drugs (01.06.2005)
Published in Investigational new drugs (01.06.2005)
Get full text
Journal Article
Prospective International Randomized Phase II Study of Low-Dose Abiraterone With Food Versus Standard Dose Abiraterone In Castration-Resistant Prostate Cancer
Szmulewitz, Russell Z, Peer, Cody J, Ibraheem, Abiola, Martinez, Elia, Kozloff, Mark F, Carthon, Bradley, Harvey, R Donald, Fishkin, Paul, Yong, Wei Peng, Chiong, Edmund, Nabhan, Chadi, Karrison, Theodore, Figg, William D, Stadler, Walter M, Ratain, Mark J
Published in Journal of clinical oncology (10.05.2018)
Published in Journal of clinical oncology (10.05.2018)
Get full text
Journal Article
Utility of flow cytometry immunophenotyping for the diagnosis and classification of lymphoma in community hospital clinical needle aspiration/biopsies
Siebert, J D, Weeks, L M, List, L W, Kugler, J W, Knost, J A, Fishkin, P A, Goergen, M H
Published in Archives of pathology & laboratory medicine (1976) (01.12.2000)
Published in Archives of pathology & laboratory medicine (1976) (01.12.2000)
Get full text
Journal Article
CPT-11 for bile-duct and gallbladder carcinoma: a phase II North Central Cancer Treatment Group (NCCTG) study
Alberts, Steven R, Fishkin, Paul A, Burgart, Lawrence J, Cera, Peter J, Mahoney, Michelle R, Morton, Roscoe F, Johnson, Patricia A, Nair, Suresh, Goldberg, Richard M
Published in International journal of gastrointestinal cancer (2002)
Published in International journal of gastrointestinal cancer (2002)
Get full text
Journal Article
Long Term Follow up of the Resort Study (E4402): A Randomized Phase III Study Comparing Two Different Rituximab Dosing Strategies for Low Tumor Burden Follicular Lymphoma
Kahl, Brad S., Hong, Fangxin, Peterson, Christopher, Swinnen, Lode J., Habermann, Thomas M., Schuster, Stephen J, Weiss, Matthias, Fishkin, Paul A S, Ehmann, W. Christopher, Fenske, Timothy S., Williams, Michael E.
Published in Blood (23.11.2021)
Published in Blood (23.11.2021)
Get full text
Journal Article
Phase I/II Clinical Trial of Temsirolimus and Lenalidomide in Patients with Relapsed and Refractory Lymphomas
Major, Ajay, Kline, Justin, Karrison, Theodore G., Fishkin, Paul A S, Kimball, Amy S, Petrich, Adam M, Nattam, Sreenivasa, Sleckman, Bethany G, Cohen, Kenneth, van Besien, Koen, Rapoport, Aaron P., Smith, Sonali M.
Published in Blood (05.11.2020)
Published in Blood (05.11.2020)
Get full text
Journal Article
Comparison of lymphoid neoplasm classification : A blinded study between a community and an academic setting
SIEBERT, James D, HARVEY, Leigh Anne C, FISHKIN, Paul A. S, KNOST, James A, EHSAN, Aamir, SMIR, Bassam N, CRAIG, Fiona E
Published in American journal of clinical pathology (01.05.2001)
Published in American journal of clinical pathology (01.05.2001)
Get full text
Journal Article
Prospective Phase I Multi-Center Trial Incorporating Lenalidomide (LEN) into Dose-Adjusted EPOCH Plus Rituximab (DA-EPOCH-R) in Patients with Double Hit (DHL) or Double Expressing (DEL) Lymphomas: Final Results
Nabhan, Chadi, Karrison, Theodore, Kline, Justin, Cohen, Kenneth, Bishop, Michael R., Karmali, Reem, Rapoport, Aaron P., Venugopal, Parameswaran, Wade, James, Fishkin, Paul, Smith, Sonali M.
Published in Blood (02.12.2016)
Published in Blood (02.12.2016)
Get full text
Journal Article
Relative frequencies and sites of presentation of lymphoid neoplasms in a community hospital according to the revised European-American classification
SIEBERT, J. D, MULVANEY, D. A, POTTER, K. L, FISHKIN, P. A. S, GEOFFROY, F. J
Published in American journal of clinical pathology (01.03.1999)
Published in American journal of clinical pathology (01.03.1999)
Get full text
Journal Article
A prospective international randomized phase II study evaluating the food effect on the pharmacokinetics (PK) and pharmacodynamics (PD) of abiraterone acetate (AA) in men with castration-resistant prostate cancer (CRPC)
Szmulewitz, Russell Zelig, Ibraheem, Abiola Falilat, Peer, Cody J., Figg, William Douglas, Carthon, Bradley Curtis, Kozloff, Mark, Harvey, Donald, Fishkin, Paul A. S., Yong, Wei Peng, Chiong, Edmund, Nabhan, Chadi, O'Donnell, Peter H., Stadler, Walter Michael, Ratain, Mark J.
Published in Journal of clinical oncology (20.02.2017)
Published in Journal of clinical oncology (20.02.2017)
Get full text
Journal Article
Dynamic contrast enhanced-MRI (DCE-MRI) as a pharmacodynamic biomarker for pazopanib (PZ) in metastatic renal carcinoma (RC)
Sweis, Randy F., Medved, Milica, Towey, Shannon, Karczmar, Greg S., Oto, Aytekin, Szmulewitz, Russell Zelig, O'Donnell, Peter H., Fishkin, Paul A. S., Stadler, Walter Michael
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
Concurrent EGFR Mutation and ALK Translocation in Non-Small Cell Lung Cancer
Sweis, Randy F, Thomas, Sachdev, Bank, Bruce, Fishkin, Paul, Mooney, Colin, Salgia, Ravi
Published in Curēus (Palo Alto, CA) (26.02.2016)
Published in Curēus (Palo Alto, CA) (26.02.2016)
Get full text
Journal Article